Screener
Opus Genetics IRD Q2 2026 earnings
Reported August 6, 2026 · Before market open
Revenue$755.0KMiss by $1.9M
EPS-$0.14Beat by $0.02
Revenue estimate$2.6M
EPS estimate-$0.16
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$1.5M
EPS estimate-$0.14
Valuation & ratios
Valuation
as of 09/17/26Versus estimates
Revenue
Diluted EPS
FAQ
- When did Opus Genetics report Q2 2026 earnings?
- Opus Genetics (IRD) reported Q2 2026 earnings on August 6, 2026 before market open.
- What were Opus Genetics's Q2 2026 revenue and EPS?
- Opus Genetics reported revenue of $755.0K and eps of $-0.14 for Q2 2026.
- Did Opus Genetics beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $2.6M by $1.9M. EPS beat the consensus estimate of $-0.16 by $0.02.
- How did Opus Genetics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 73.8% from $2.9M a year earlier and eps declined 16.7% from $-0.12.
- Where can I find Opus Genetics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-053824) and the 10-Q periodic report (0001628280-26-054381) directly on SEC EDGAR. The filing index links above go to sec.gov.
